Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-03-12

FDA Approved: CEFOXITIN — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved an original ANDA for cefoxitin by Hikma Pharmaceuticals USA, enabling a generic version of cefoxitin for its indicated infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefoxitin (Cefoxitin)

Snippet

ORIG AP for CEFOXITIN (CEFOXITIN)